학술논문

Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial
Document Type
Article
Source
In: eClinicalMedicine. (eClinicalMedicine, November 2022, 53)
Subject
Language
English
ISSN
25895370